Current bronchiolitis management guidelines [1] suggest that viral testing is not necessary in children admitted with symptoms of bronchiolitis, but bronchiolitis is a clinical diagnosis that has many ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal ...

Bronchiolitis is defined as an acute inflammation of bronchioles in the lower respiratory tract that results in airway obstruction with accompanying progressive dyspnea and poor feeding. This ...

Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol ...

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Bronchiolitis ...

Ziresovir significantly improved clinical outcomes and reduced RSV viral load in infants compared to placebo in a phase 3 trial. The trial involved infants aged 1 to 24 months, with ziresovir showing ...

The consultation files of the author were searched for all cases referred to the author in consultation as possible ‘nonspecific interstitial pneumonia’ from 2000 to 2006. Of these 32 cases, nine ...

Please provide your email address to receive an email when new articles are posted on . There was a 75.3% rise in bronchiolitis admissions in 2022 to 2023 compared with the median before COVID-19.

Infants given acetaminophen (also called paracetamol; brand name, Tylenol) for pain or fever relief in their first year were ...

A jab to protect against one of the most common winter bugs will be offered to children and older adults within a year, a top vaccine chief has revealed. The Government’s inoculation advisory group ...

DelveInsight’s Bronchiolitis Obliterans Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, bronchiolitis obliterans syndrome emerging drugs, market ...